Jakafi 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FPRM0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,276
Award facts
- Contract value 100% obligated
- $24,276.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24.3K to DMS Pharmaceutical Group Inc. for Jakafi 5 mg tablets (60-count supply) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a direct pharmaceutical supply to support Department of Defense healthcare requirements. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor for this delivery.
This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499.9M through November 2026. The parent IDC, awarded under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products, branded and generic prescription drugs, biologics, and medical consumables to support military health facilities worldwide. Jakafi, an oncology treatment medication, aligns with the contractor's demonstrated portfolio of specialty pharmaceutical products delivered to federal healthcare systems. The contractor's consistent receipt of delivery orders without set-aside designations reflects its competitive positioning as an established woman-owned small business within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FPRM0?
SPE2DB25FPRM0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FPRM0 worth?
The government has obligated $24,276 on SPE2DB25FPRM0.
Is contract SPE2DB25FPRM0 an order under another contract?
Yes. SPE2DB25FPRM0 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRM0 competed?
The extent of competition for SPE2DB25FPRM0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award